A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality, China

Fujian Cancer Hospital, Fuzhou, Fujian, China

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Zhangzhou Municiple Hospital of Fujian Province, Zhangzhou, Fujian, China

Dongguan People's Hospital, Dongguan, Guangdong, China

Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, China

Jiangmen Central Hospital, Jiangmen, Guangdong, China

Yuebei People's Hospital, Shaoguan, Guangdong, China

The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China

Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China

The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China

Hunan Cancer Hospital, Changsha, Hunan, China

Jiangxi Cancer Hospital, Nanchang, Jiangxi, China

The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

Sichuan Cancer Hospital, Chengdu, Sichuan, China

Yunnan Cancer Hospital, Kunming, Yunnan, China

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China